GLP-1 drugs and bad breath: what's actually causing it
Quick answer
GLP-1 receptor agonists like semaglutide and tirzepatide slow gastric emptying as part of their mechanism of action, which can cause prolonged fermentation of food in the stomach and increased production of hydrogen sulfide gas, resulting in sulfur-smelling burps. This is a documented gastrointestinal side effect category confirmed in FDA adverse event data and clinical trial GI reporting. Patients transitioning between GLP-1 agents or escalating doses, as this creator describes doing, may notice changes in symptom intensity, though direct head-to-head comparative GI data between semaglutide and tirzepatide remains limited.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @bossl8t actually say?
The creator is asking a crowd-sourced question, not making a medical claim, and credit goes to them for being upfront about that. They describe burps that smell "horrible" since starting GLP-1 medications, first semaglutide, now tirzepatide. Their grandkid thought they passed gas. They want to know if other users are experiencing the same thing and whether the drug type matters.
This is anecdotal, but it reflects a real and widely reported side effect pattern. The creator isn't diagnosing anything or selling a solution. They're doing what millions of GLP-1 users do: trying to make sense of something their body is doing that nobody warned them about. That framing matters when evaluating what they got right.
Does the science back this up?
Yes, actually. Sulfur burps are a legitimate, documented side effect of GLP-1 receptor agonists, and the mechanism isn't mysterious. GLP-1 drugs slow gastric emptying, which means food, particularly protein, sits in your stomach longer than usual. That extended fermentation produces hydrogen sulfide gas. That is what smells like rotten eggs.
A 2023 FDA adverse event report analysis published in JAMA Internal Medicine (Sodhi et al., 2023) confirmed that gastrointestinal side effects including eructation (the clinical word for burping) are significantly more common with semaglutide than with other weight-loss interventions. The slowed gastric emptying effect is well-established in clinical pharmacology literature going back to early GLP-1 studies (Nauck et al., 2011, Diabetes Care). The smell is not imaginary, and it is not rare. Online communities for semaglutide and tirzepatide users are full of identical complaints, which aligns with the mechanism.
What did they get wrong (or right)?
They got the core observation right. Where things get murkier is the implicit suggestion that this might differ between semaglutide and tirzepatide. The creator asks commenters to specify which drug they're on, hinting at a difference. That's an interesting hypothesis but there's no published clinical trial directly comparing sulfur burp frequency between the two drugs.
Tirzepatide targets both GIP and GLP-1 receptors, making it a dual agonist, and its effects on gastric motility may differ in degree from semaglutide. A 2022 trial in The New England Journal of Medicine (Jastreboff et al., SURMOUNT-1) documented higher rates of nausea and GI events with tirzepatide at higher doses compared to placebo, but head-to-head GI comparisons with semaglutide are limited. So the creator is asking a reasonable clinical question that science hasn't fully answered yet. That's not a flaw in their reasoning. It's a gap in the research.
What should you actually know?
If you're on a GLP-1 drug and your burps smell bad, you are not alone and you are not imagining it. The slowed gastric emptying that makes these drugs effective for weight loss is the same mechanism creating that smell. A few things are worth knowing. High-protein diets, which many GLP-1 users adopt, can worsen hydrogen sulfide production. Eating smaller meals, chewing thoroughly, and avoiding carbonated drinks may reduce the frequency.
Some clinicians recommend probiotics or digestive enzymes as adjunct support, though evidence for these specifically in GLP-1 users is limited. If burping is accompanied by significant abdominal pain, vomiting, or feels like it is getting worse over time rather than stabilizing, that warrants a conversation with a prescriber. Gastroparesis, a more serious delay in stomach emptying, has been flagged in post-market GLP-1 case reports and should not be dismissed as just a burp problem if symptoms are severe.
- Sulfur burps are caused by delayed gastric emptying, not a random drug quirk.
- High-protein intake worsens hydrogen sulfide gas production in the stomach.
- Eating smaller, slower meals can reduce symptom frequency.
- Severe or worsening GI symptoms should be reported to a prescriber.
Bottom line
@bossl8t described a real pharmacological side effect using a car-ride analogy instead of clinical language. Both are valid. The mechanism is understood, the experience is common, and the question about whether semaglutide versus tirzepatide produces worse smells is genuinely unanswered by current literature. If your doctor put you on one of these medications and didn't mention this possibility, that is a gap in patient counseling worth raising at your next visit.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Compounded Semaglutide access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For GLP-1 drugs and bad breath: what's actually causing it, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Tirzepatide Once Weekly for the Treatment of Obesity
Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.
PubMed
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction
Used for continuation, stopping, and maintenance questions after initial weight loss.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this semaglutide video claims cluster
Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.
Claim verdict
The useful answer behind this video
Claim being checked
GLP-1 receptor agonists like semaglutide and tirzepatide slow gastric emptying as part of their mechanism of action, which can cause prolonged fermentation of food in the stomach and increased production of hydrogen sulfide gas, resulting in sulfur-smelling burps.
FormBlends verdict
GLP-1 receptor agonists like semaglutide and tirzepatide slow gastric emptying as part of their mechanism of action, which can cause prolonged fermentation of food in the stomach and increased production of hydrogen sulfide gas, resulting in sulfur-smelling burps. This is a documented gastrointestinal side effect category confirmed in FDA adverse event data and clinical trial GI reporting. Patients transitioning between GLP-1 agents or escalating doses, as this creator describes doing, may notice changes in symptom intensity, though direct head-to-head comparative GI data between semaglutide and tirzepatide remains limited.
Patient-safe next step
Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- GLP-1 receptor agonists like semaglutide and tirzepatide slow gastric emptying as part of their mechanism of action, which can cause prolonged fermentation of food in the stomach and increased production of hydrogen sulfide gas, resulting in sulfur-smelling burps. This is a documented gastrointestinal side effect category confirmed in FDA adverse event data and clinical trial GI reporting. Patients transitioning between GLP-1 agents or escalating doses, as this creator describes doing, may notice changes in symptom intensity, though direct head-to-head comparative GI data between semaglutide and tirzepatide remains limited.
- GLP-1 drugs slow gastric emptying by design, and that delay allows stomach contents to ferment longer, producing hydrogen sulfide gas responsible for sulfur-smelling burps.
- Sodhi et al., 2023, JAMA Internal Medicine confirmed GI adverse events including eructation are significantly more common with semaglutide than non-GLP-1 weight-loss interventions.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.
Review Compounded SemaglutideWhat You'll Learn
- GLP-1 drugs slow gastric emptying by design, and that delay allows stomach contents to ferment longer, producing hydrogen sulfide gas responsible for sulfur-smelling burps.
- Sodhi et al., 2023, JAMA Internal Medicine confirmed GI adverse events including eructation are significantly more common with semaglutide than non-GLP-1 weight-loss interventions.
- High-protein diets common among GLP-1 users increase hydrogen sulfide production, likely worsening the sulfur smell the creator describes.
- No clinical trial has directly compared sulfur burp frequency between semaglutide and tirzepatide, making the creator's question about drug-specific differences a legitimate but currently unanswerable one.
- Eating smaller meals, slowing eating pace, and reducing carbonated beverage intake are practical steps that may reduce burp frequency, though GLP-1-specific evidence for these interventions is thin.
- Severe, worsening, or painful GI symptoms on GLP-1 therapy should be reported to a prescriber because post-market case reports have flagged gastroparesis as a rare but serious complication.
- Patients who were not counseled on GI side effects before starting GLP-1 therapy should raise this with their prescriber, as it affects quality of life and medication adherence.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Lemme Get This 💩 Straight™️ · TikTok creator
8.5K views on this video
Do yall breath smell worse since you been taking the GLP’s? 🤔 #weightloss #semaglutide #tirzepatide #tirzepatidejourney
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Lemme Get This 💩 Straight™️, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.